Skip to Content

Maraviroc Disease Interactions

There are 4 disease interactions with maraviroc:

Major

Maraviroc (Includes maraviroc) ↔ hepatotoxicity/liver impairment

Severe Potential Hazard, Moderate plausibility. Applies to: Liver Disease

Hepatotoxicity has been reported with the use of maraviroc. Symptoms of systemic allergic reaction (pruritic rash, eosinophilia, or elevated Ig E), prior to the development of hepatotoxicity may occur. Patients with signs or symptoms of hepatitis or allergic reaction should be evaluated immediately. Additionally, the safety and efficacy of maraviroc has not been studied in patients with significant underlying liver disorders. Caution should be used when administering maraviroc to patients with preexisting liver dysfunction or who are coinfected with viral hepatitis B or C.

Major

Maraviroc (Includes maraviroc) ↔ renal impairment

Severe Potential Hazard, Moderate plausibility. Applies to: Renal Dysfunction

An increased risk of postural hypotension may occur in patients with severe renal impairment or those with end-stage renal disease, due to increased exposure to maraviroc. This drug should be used with caution in these patients only if they are not receiving a concomitant potent CYP3A inhibitor or inducer, and therapy should be considered only when there is no other treatment option. A dose reduction might be necessary if any symptoms of postural hypotension are experienced. No studies have been performed in patients with severe renal impairment (CrCl < 30 mL/min) or ESRD who are taking concomitant CYP3A inhibitors or inducers, and maraviroc is contraindicated on these patients.

Moderate

Maraviroc (Includes maraviroc) ↔ cardiovascular disease

Moderate Potential Hazard, Moderate plausibility. Applies to: Cardiovascular Disease

Maraviroc should be used with caution in patients at increased risk of cardiovascular events as there have been reports of events including myocardial ischemia and infarction in Phase 3 trials.

Moderate

Maraviroc (Includes maraviroc) ↔ hypotension

Moderate Potential Hazard, Moderate plausibility. Applies to: Hypotension, Hypertension

Symptomatic postural hypotension has been frequently reported with maraviroc. Caution should be used when administering maraviroc in patients with a history of postural hypotension or receiving concomitant medication known to lower blood pressure.

Maraviroc drug interactions

There are 396 drug interactions with maraviroc

Maraviroc alcohol/food interactions

There are 2 alcohol/food interactions with maraviroc

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide